Showing results (371-380 of 6,708) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|March 1, 2017
The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapyXuemei Liu, Minghuan Li, Fen Zhao, et al.
Oncotargets and Therapy|March 1, 2017
miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinomaFei Xie, Yuncang Yuan, Luyang Xie, et al.
Oncotargets and Therapy|March 1, 2017
Polydatin regulates proliferation, apoptosis and autophagy in multiple myeloma cells through mTOR/p70s6k pathwayBaojun Yang, Shunxin Zhao
Oncotargets and Therapy|February 17, 2017
miR-17 as a diagnostic biomarker regulates cell proliferation in breast cancerFangliang Yang, Yuan Li, Lingyun Xu, et al.
Oncotargets and Therapy|February 17, 2017
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of lifeStefano Severi, Ilaria Grassi, Silvia Nicolini, et al.
Oncotargets and Therapy|February 17, 2017
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lungTomoki Nakamura, Akihiko Matsumine, Motoshi Takao, et al.
Oncotargets and Therapy|February 17, 2017
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trialJosep Tabernero, Volker Kunzmann, Werner Scheithauer, et al.
Oncotargets and Therapy|October 6, 2016
Identifying module biomarkers from gastric cancer by differential correlation networkXiaoping Liu, Xiao Chang
Oncotargets and Therapy|October 6, 2016
Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancerXin Wang, Feifei Teng, Li Kong, et al.
Oncotargets and Therapy|October 6, 2016
A case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-PD-1 after failure of autologous stem cell transplantation and brentuximab vedotinPeipei Xu, Fan Wang, Chaoyang Guan, et al.
Pageof 671